Frequently Asked Questions About Ketamine Therapy

Ketamine infusion therapy is safe when administered by trained medical professionals in a clinical setting, with careful dosing, monitoring, and patient assessment. Side effects are usually short-lived but can vary between individuals. Evaluation is essential for patients with specific medical or psychiatric conditions. Safety depends on proper administration and assessment. Self-administration outside of a clinical setting is dangerous and can lead to serious consequences, including addiction and long-term harm. We uphold the highest safety standards in our practice and adhere to ethics and standards set by American Society of Ketamine Physicians, Psychotherapists & Practitioners. For more detailed information, please visit ASKP3. Your well-being is our top priority, and we’re committed to ensuring a safe and supportive environment for your treatment.

We do not offer at-home prescribing. Ketamine should always be administered by trained medical professionals in a clinical setting. 

Contraindications include allergies to ketamine, uncontrolled high blood pressure, severe heart conditions, significant liver or kidney disease, a history of severe psychotic disorders, active substance abuse, certain medications, pregnancy or breastfeeding, acute physical illness, and a history of ketamine abuse. 

Ketamine, when used as prescribed in medical settings, has a low potential for addiction. It is classified as a Schedule III controlled substance due to the potential for abuse, but the risk is relatively low compared to many other substances. Ketamine’s addictive properties are more likely to manifest when used recreationally in higher doses or in a non-medical context. Individuals with a history of substance abuse may be at a slightly higher risk. However, under the supervision of qualified healthcare professionals in a controlled clinical setting, where doses are carefully monitored, the risk of addiction is minimal. 

At this time, our center specializes in intravenous racemic ketamine infusion therapy. We continually evaluate the potential of providing SPRAVATO® (esketamine) treatment in the future.

At this time, the majority of insurance companies do not pay for ketamine infusion treatments. Some insurance companies cover ketamine infusion therapy on occasion. We are happy to provide a superbill you can use for partial out-of-network reimbursement.

Subanesthetic dosing is considered 0.5-2 mg/kg over 40 minutes to one hour. This is compared to anesthetic dosing of ketamine which is typically begin at 2mg/kg.

We acknowledge the dedication required to undergo ketamine infusion therapy. Our team will collaborate with you to establish an optimal treatment schedule that suits your needs.

We accept FSA/HSA cards, all major credit cards and personal checks. Interest-free financing is available through Advance Care Card.

Flexible financing options are available through Care Credit. 

We provide discounts for veterans, first responders, and medical personnel.